De novo Drug Design

AI-driven de novo drug design aims to generate new chemical entities with desired properties in a cost- and time-efficient manner. The ability of approaches provided by MedAI's AI platform to generate innovative molecular cores has been proved, thereby exploring novel regions of the chemical space. Learn more at aimed.protheragen.com/de-novo-drug-design.html

Done